Michael Truett Tate sold $1.5M of ALAB
Chief Financial Officer at Astera Labs, Inc.. 12,001 shares at an average of $123.81, traded Feb 17, 2026, filed Feb 19, 2026.
Score components
- +22RoleCFO
- +25Trade size$1.5M at market
- 0Share of holdings soldSold 5.9% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -12.5%, 3m +124.6%, 6m +119.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001399546-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | SOpen-market sale Common Stock | -753 | $122.16 | $92k | 203,331 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -4,250 | $122.84 | $522k | 199,081 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -3,556 | $123.93 | $441k | 195,525 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -2,281 | $124.66 | $284k | 193,244 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -1,161 | $126.34 | $147k | 192,083 | Feb 19, 2026 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 65Notable | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $31M 90,630 shares | -7% | |
| 55Moderate | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $2.3M 6,801 shares | -7% | |
| 60Notable | Astera Labs, Inc. | Sanjay Gajendra President and COO | $31M 90,630 shares | -7% | |
| 40Moderate | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.9M 12,499 shares | -22% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $61M 136,974 shares | -10% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $17M 37,535 shares | -3% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $3.9M 8,491 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.